Flora Growth (FLGC)
(Real Time Quote from BATS)
$1.70 USD
+0.01 (0.59%)
Updated Apr 23, 2024 12:06 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Flora Growth Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 76 | 37 | 9 | 0 | 0 |
Cost Of Goods | 58 | 23 | 7 | 0 | 0 |
Gross Profit | 18 | 14 | 2 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 45 | 42 | 19 | 12 | 0 |
Income After Depreciation & Amortization | -27 | -28 | -17 | -12 | 0 |
Non-Operating Income | -21 | -26 | -5 | -2 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -48 | -54 | -21 | -14 | 0 |
Income Taxes | -2 | -2 | 0 | 0 | 0 |
Minority Interest | 1 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -47 | -53 | -21 | -14 | 0 |
Extras & Discontinued Operations | -10 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -57 | -52 | -21 | -14 | 0 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -25 | -25 | -16 | -12 | 0 |
Depreciation & Amortization (Cash Flow) | 2 | 3 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -27 | -28 | -17 | -12 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 7.36 | 3.83 | 2.20 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.72 | -13.60 | -9.80 | NA | NA |
Diluted Net EPS (GAAP) | -7.75 | -13.60 | -9.60 | -3.20 | NA |
Fiscal Year end for Flora Growth Corp falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 17.19 | 17.32 | 21.46 | 20.11 |
Cost Of Goods | NA | 13.83 | 12.38 | 17.50 | 14.63 |
Gross Profit | NA | 3.36 | 4.94 | 3.96 | 5.48 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | -13.34 | 5.49 | 44.01 | 8.56 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 16.70 | -0.55 | -40.05 | -3.08 |
Non-Operating Income | NA | -0.09 | 1.14 | 1.98 | -0.87 |
Interest Expense | NA | 0.03 | 0.02 | 0.03 | 0.02 |
Pretax Income | NA | -6.79 | 0.58 | -38.11 | -3.97 |
Income Taxes | NA | -0.39 | -0.05 | -1.12 | -0.07 |
Minority Interest | NA | 1.10 | -0.12 | -0.27 | -0.03 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -6.40 | 0.63 | -36.99 | -3.91 |
Extras & Discontinued Operations | NA | -2.61 | 0.49 | -7.57 | 0.00 |
Net Income (GAAP) | NA | -10.11 | 1.24 | -44.29 | -3.88 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 7.64 | 6.73 | 6.64 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.05 | -0.31 | -0.60 |
Diluted Net EPS (GAAP) | NA | -0.73 | 0.16 | -6.58 | -0.60 |